Mirati Therapeutics (NASDAQ:MRTX) Coverage Initiated at StockNews.com
StockNews.com started coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a report published on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. Other research analysts have also recently issued reports about the stock. Scotiabank upgraded shares of Mirati Therapeutics from an underperform rating to a sector perform […]
More Stories
Western Copper & Gold (NYSE:WRN) and Mountain Province Diamonds (OTCMKTS:MPVDF) Critical Contrast
Western Copper & Gold (NYSE:WRN – Get Free Report) and Mountain Province Diamonds (OTCMKTS:MPVDF – Get Free Report) are both...
iExec RLC (RLC) Price Reaches $1.49 on Top Exchanges
iExec RLC (RLC) traded down 1.4% against the dollar during the 24-hour period ending at 0:00 AM Eastern on October...
XIDO FINANCE (XIDO) Achieves Self Reported Market Capitalization of $20.93 Million
XIDO FINANCE (XIDO) traded 4.6% higher against the U.S. dollar during the 24-hour period ending at 0:00 AM ET on...
NULS Price Tops $0.33 on Exchanges (NULS)
NULS (NULS) traded 0.3% lower against the US dollar during the 1-day period ending at 0:00 AM E.T. on October...
Lido DAO (LDO) Reaches 24 Hour Volume of $58.59 Million
Lido DAO (LDO) traded 1.9% lower against the US dollar during the 24 hour period ending at 0:00 AM Eastern...
Nexum Reaches Self Reported Market Capitalization of $4.33 Million (NEXM)
Nexum (NEXM) traded down 2.6% against the U.S. dollar during the twenty-four hour period ending at 0:00 AM Eastern on...